Oxford BioMedica PLC (OXB)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
629.00p
Buy
635.00p
-15.00p (-2.34%)
Prices updated at 12 Dec 2025, 17:00 GMT
| Prices minimum 15 mins delay
Prices in GBX
Oxford BioMedica PLC is a biopharmaceutical company based in the United Kingdom. It develops gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | 41.17 |
| 2023 | 44.37 |
| 2022 | 49.42 |
| 2021 | 57.87 |
| 2020 | 52.52 |
| 2019 | 44.24 |
| 2018 | 50.19 |
| 2017 | 50.94 |
| 2016 | 57.39 |
| 2015 | 63.30 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 4.30 |
| 2024 | 4.36 |
| 2023 | 1.78 |
| 2022 | 3.39 |
| 2021 | 7.64 |
| 2020 | 12.01 |
| 2019 | 7.03 |
| 2018 | 8.07 |
| 2017 | 8.54 |
| 2016 | 4.44 |
| 2015 | 12.50 |
Price/Forward earnings (YTD)
212.77
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | -17.85 |
| 2023 | -44.21 |
| 2022 | -11.23 |
| 2021 | 9.03 |
| 2020 | -4.07 |
| 2019 | -13.65 |
| 2018 | 8.48 |
| 2017 | -14.74 |
| 2016 | -30.59 |
| 2015 | -30.40 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 4.06 |
| 2023 | 3.41 |
| 2022 | 2.25 |
| 2021 | 1.27 |
| 2020 | 1.63 |
| 2019 | 1.63 |
| 2018 | 3.24 |
| 2017 | 10.64 |
| 2016 | 4.51 |
| 2015 | 4.76 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
